Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP

Immunobiology

Volumn 217, Issue 7, 2012, Pages 684-691

  Radanova, Maria ^a   Vasilev, Vasil ^b   Deliyska, Boriana ^b   Kishore, Uday ^c   Ikonomov, Valentin ^d   Ivanova, Diana ^a  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^b UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^c BRUNEL UNIVERSITY   (United Kingdom)

^d UNIVERSITY HOSPITAL ST MARINA   (Bulgaria)

Author keywords

Anti C1q autoantibodies; C1q; C1q b chain; IgG; Lupus nephritis

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C1QA CHAIN; COMPLEMENT COMPONENT C1QB CHAIN; COMPLEMENT COMPONENT C1QC CHAIN; EPITOPE; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADULT; ANTIBODY ISOLATION; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; BINDING KINETICS; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

ADULT; AUTOANTIBODIES; BINDING SITES, ANTIBODY; C-REACTIVE PROTEIN; COMPLEMENT C1Q; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN G; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX;

EID: 84861184735     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.11.007     Document Type: Article

References (36)

1. Botto M., Walport M.J. C1q, autoimmunity and apoptosis. Immunobiology 2002, 205:395-406.
2. Flierman R., Daha M.R. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis - a hypothesis. Mol. Immunol. 2007, 44:133-138.
3. Frémeaux-Bacchi V., Noël L.H., Schiffer J.A. No lupus nephritis in the absence of antiC1q autoantibodies?. Nephrol. Dial. Transplant. 2004, 17:2041-2043.
4. Gaboriaud C., Juanhuix J., Gruez A., Lacroix M., Darnault C., Pignol D., Verger D., Fontecilla-Camps J.C., Arlaud G.J. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J. Biol. Chem. 2003, 278:46974-46982.
5. Gadjeva M.G., Rouseva M.M., Zlatarova A.S., Reid K.B., Kishore U., Kojouharova M.S. Interaction of human C1q with IgG and IgM: revisited. Biochemistry 2008, 47:13093-13102.
6. Ghai R., Waters P., Roumenina L.T., Gadjeva M., Kojouharova M.S., Reid K.B.M., Sim R.B., Kishore U. C1q and its growing family. Immunobiology 2007, 212:253-266.
7. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
8. Holers V.M. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus. J. Clin. Invest. 2004, 114:616-619.
9. Kishore U., Gaboriaud C., Waters P., Shrive A.K., Greenhough T.J., Reid K.B., Sim R.B., Arlaud G.J. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol. 2004, 25:551-561.
10. Kishore U., Gupta S.K., Perdikoulis M.V., Kojouharova M.S., Urban B.C., Reid K.B. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains. J. Immunol. 2003, 171:812-820.
11. Kishore U., Reid K.B. Modular organization of proteins containing C1q-like globular domain. Immunopharmacology 1999, 42:15-21.
12. Kojouharova M.S., Gadjeva M.G., Tsacheva I.G., Zlatarova A., Roumenina L.T., Tchorbadjieva M.I., Atanasov B.P., Waters P., Urban B.C., Sim R.B., Reid K.B., Kishore U. Mutational analyses of the recombinant globular regions of human C1q A, B, and C chains suggest an essential role for arginine and histidine residues in the C1q-IgG interaction. J. Immunol. 2004, 172:4351-4358.
13. Mannik M., Wener M.H. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 1997, 40:1504-1511.
14. Marto N., Bertolaccini M.L., Calabuig E., Hughes G.R., Khamashta M.A. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann. Rheum. Dis. 2005, 64:444-448.
15. Mok C.C., Ho L.Y., Leung H.W., Wong L.G. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Transl. Res. 2010, 156:320-325.
16. Moroni G., Trendelenburg M., Del Papa N., Quaglini S., Raschi E., Panzeri P., Testoni C., Tincani A., Banfi G., Balestrieri G., Schifferli J.A., Meroni P.L., Ponticelli C. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J. Kidney Dis. 2001, 37:490-498.
17. Namjou B., Gray-McGuire C., Sestak A.L., Gilkeson G.S., Jacob C.O., Merrill J.T., James J.A., Wakeland E.K., Li Q.Z., Langefeld C.D., Divers J., Ziegler J., Moser K.L., Kelly J.A., Kaufman K.M., Harley J.B. Evaluation of C1q genomic region in minority racial groups of lupus. Genes Immun. 2009, 10:517-524.
18. Nayak A., Pedenekar L., Reid K.B., Kishore U. Complement and non-complement activating functions of C1q: a prototypical innate immune molecule. Innate Immun. Mar. 2011, 30. 10.1177/1753425910396252.
19. Nayak A., Ferluga J., Tsolaki A.G., Kishore U. The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol. Lett. 2010, 131:139-150.
20. Pickering M.C., Botto M., Taylor P.R., Lachmann P.J., Walport M.J. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 2000, 76:227-324.
21. Roumenina L., Bureeva S., Kantardjiev A., Karlinsky D., Andia-Pravdivy J.E., Sim R., Kaplun A., Popov M., Kishore U., Atanasov B. Complement C1q-target proteins recognition is inhibited by electric moment effectors. J. Mol. Recognit. 2007, 20:405-415.
22. 2+ in the electrostatic stability and the functional activity of the globular domain of human C1q. Biochemistry 2005, 44:14097-14109.
23. Roumenina L.T., Popov K.T., Bureeva S.V., Kojouharova M., Gadjeva M., Rabheru S., Thakrar R., Kaplun A., Kishore U. Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide. Biochim. Biophys. Acta 2008, 1784:1271-1276.
24. Roumenina L.T., Ruseva M.M., Zlatarova A., Ghai R., Kolev M., Olova N., Gadjeva M., Agrawal A., Bottazzi B., Mantovani A., Reid K.B., Kishore U., Kojouharova M.S. Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains. Biochemistry 2006, 45:4093-4104.
25. Schaller M., Bigler C., Danner D., Ditzel H.J., Trendelenburg M. Autoantibodies against C1q in Systemic Lupus Erythematosus are antigen-driven. J. Immunol. 2009, 183:8225-8231.
26. Schejbel L., Skattum L., Hagelberg S., Ahlin A., Schiller B., Berg S., Genel F., Truedsson L., Garred P. Molecular basis of hereditary C1q deficiency-revisited: identification of several novel disease-causing mutations. Genes Immun. 2011, 12:626-634.
27. Siegert C.E., Kazatchkine M.D., Sjoholm A., Wurzner R., Loos M., Daha M.R. Autoantibodies against C1q: view on clinical relevance and pathogenic role. Clin. Exp. Immunol. 1999, 116:4-8.
28. Sinico R.A., Radice A., Ikehata M., Giammarresi G., Corace C., Arrigo G., Bollini B., Li Vecchi M. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Ann. N. Y. Acad. Sci. 2005, 1050:193-200.
29. Tan Y., Zhou W., Yu F., Fang Q., Yang H.Z., Zhao M.H. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis. Mol. Immunol. 2009, 46:2178-2182.
30. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 2000, 192:359-366.
31. Trendelenburg M., Lopez-Trascasa M., Potlukova E., Moll S., Regenass S., Fremeaux-Bacchi V., Martinez-Ara J., Jancova E., Picazo M.L., Honsova E., Tesar V., Sadallah S., Schifferli J. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol. Dial. Transplant. 2006, 21:3115-3121.
32. Trendelenburg M., Schifferli J.A. Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus. Z. Rheumatol. 2000, 59:172-175.
33. Trouw L.A., Groeneveld T.W.L., Seelen M.A., Duijs J.M.G.J., Bajema I.M., Prins F., Kishore U., Salant D.J., Verbeek S.J., van Cooten C., Daha M.R. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J. Clin. Invest. 2004, 114:679-688.
34. Tsacheva I., Radanova M., Todorova N., Argirova T., Kishore U. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients. Mol. Immunol. 2007, 44:2147-2151.
35. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144.
36. Zlatarova A.S., Rouseva M., Roumenina L.T., Gadjeva M., Kolev M., Dobrev I., Olova N., Ghai R., Jensenius J.C., Reid K.B., Kishore U., Kojouharova M.S. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q. Biochemistry 2006, 45:9979-9988.